Live feed
Filing
SC 13G/A
SC 13G/A0001628280-15-000727·Allianz Global Investors U.S. Holdings LLC
Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001628280-15-000727
- Form type
- SC 13G/A
- Filer
- Allianz Global Investors U.S. Holdings LLC
- CIK
- CIK 1567940
- Filed
- Feb 13, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership